AlphaRM analysis shows three Binnopharm Group brands among the top 20 drugs with the largest sales increases in rubles from June 2024 to May 2025.
The antiviral drug Kagocel took the first place among OTC medicines in terms of sales growth (+38%). The company’s press service informed GxP News that Diclofenac-AKOS (+30%) and Lorotricin-Alium (+86%) were also included in the list.
“The market is becoming more competitive, so it is becoming more important to listen to the consumer. We don’t just promote products, we try to talk about things that people really care about. Anton Fedosyuk, Marketing Director of Binnopharm Group, stated, “The result of each of the brands that made it to the top 20 is a comprehensive effort involving the creative community, the medical community, the pharmacy segment, and the end user.”
